Waters and Bruker announce collaboration
Waters Corporation (Milford, Massachusetts) and Bruker BioSciences Corporation (Billerica, Massachusetts) recently entered into a collaboration agreement to provide greater integration and connectivity between Waters? ACQUITY Ultra Performance LC (UPLC) system and Bruker?s mass spectrometry (MS) and nuclear magnetic resonance (NMR) products.
Waters Corporation (Milford, Massachusetts) and Bruker BioSciences Corporation (Billerica, Massachusetts) recently entered into a collaboration agreement to provide greater integration and connectivity between Waters' ACQUITY Ultra Performance LC (UPLC) system and Bruker's mass spectrometry (MS) and nuclear magnetic resonance (NMR) products.
The collaboration will allow direct support of Waters ACQUITY UPLC system in Bruker's HyStar software thus unifying control and results management to combine these technologies. The products of both companies have many applications in the discovery, development, and manufacture of pharmaceuticals, processed foods, beverages, personal care products, and in environmental and food safety laboratories.
LC–MS/MS-Based System Used to Profile Ceramide Reactions to Diseases
April 26th 2024Scientists from the University of Córdoba in Córdoba, Spain recently used liquid chromatography–tandem mass spectrometry (LC–MS/MS) to comprehensively profile human ceramides to determine their reactions to diseases.
High-Throughput 4D TIMS Method Accelerates Lipidomics Analysis
April 25th 2024Ultrahigh-pressure liquid chromatography coupled to high-resolution mass spectrometry (UHPLC-HRMS) had been previously proposed for untargeted lipidomics analysis, but this updated approach was reported by the authors to reduce run time to 4 min.
